HCPCS Service Codes - Medical care

HCPCS Codes for Medical care

• G9909

  Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)

• G9910

  Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period

• G9911

  Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy

• G9912

  Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy

• G9913

  Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified

• G9914

  Patient initiated an anti-tnf agent

• G9915

  No record of hbv results documented

• G9916

  Functional status performed once in the last 12 months

• G9917

  Documentation of advanced stage dementia and caregiver knowledge is limited

• G9918

  Functional status not performed, reason not otherwise specified

• G9919

  Screening performed and positive and provision of recommendations

• G9920

  Screening performed and negative

• G9921

  No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified

• G9922

  Safety concerns screen provided and if positive then documented mitigation recommendations

• G9923

  Safety concerns screen provided and negative

• G9924

  Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)

• G9925

  Safety concerns screening not provided, reason not otherwise specified

• G9926

  Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources

• G9927

  Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment

• G9928

  Fda-approved anticoagulant not prescribed, reason not given

• G9929

  Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)

• G9930

  Patients who are receiving comfort care only

• G9931

  Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women

• G9932

  Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)

• G9933

  Adenoma(s) or colorectal cancer detected during screening colonoscopy

• G9934

  Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

• G9935

  Adenoma(s) or colorectal cancer not detected during screening colonoscopy

• G9936

  Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus

• G9937

  Diagnostic colonoscopy

• G9938

  Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period

• G9939

  Pathologists/dermatopathologists is the same clinician who performed the biopsy

• G9940

  Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)

• G9941

  Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively

• G9942

  Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

• G9943

  Back pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively

• G9944

  Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

• G9945

  Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis

• G9946

  Back pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively

• G9947

  Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively

• G9948

  Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy

• G9954

  Patient exhibits 2 or more risk factors for post-operative vomiting

• G9955

  Cases in which an inhalational anesthetic is used only for induction

• G9956

  Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

• G9957

  Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)

• G9958

  Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively

• G9959

  Systemic antimicrobials not prescribed

• G9960

  Documentation of medical reason(s) for prescribing systemic antimicrobials

• G9961

  Systemic antimicrobials prescribed

• G9962

  Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy

• G9963

  Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy